T. Rowe Price US Large Cap Growth Equity Fund A USD vs UBS Lux Equity Fund Biotech USD

T. Rowe Price US Large Cap Growth Equity Fund A USD vs UBS Lux Equity Fund Biotech USD

1. T. Rowe Price US Large Cap Growth Equity Fund A USD

  • Security

    T. Rowe Price US Large Cap Growth Equity Fund A USD

  • Fee

    1.59%

  • ISIN

    LU0174119429

  • Holdings

    10

2. UBS Lux Equity Fund Biotech USD

  • Security

    UBS Lux Equity Fund Biotech USD P-acc

  • Fee

    2.25%

  • ISIN

    LU0069152568

  • Holdings

    9

Fund Holdings

We have information about 20 holdings in T. Rowe Price US Large Cap Growth Equity Fund A USD, where the largest holding is Apple (9.63), followed by Nvidia (9.59) and Microsoft (9.49). In comparison with UBS Lux Equity Fund Biotech USD, we have 11 holdings where Regeneron Pharmaceuticals is the largest holding (10.04), followed by Moderna (9.21) and Vertex (8.44).

All Holdings

Here we compare the holdings in T. Rowe Price US Large Cap Growth Equity Fund A USD and UBS Lux Equity Fund Biotech USD.

T. Rowe Price US Large Cap Growth Equity Fund A USD UBS Lux Equity Fund Biotech USD
1. Apple Inc
USA
9.63 %
1. Regeneron Pharmaceuticals Inc
10.04 %
2. Nvidia Corp
USA
9.59 %
2. Moderna Inc
9.21 %
3. Microsoft Corp
USA
9.49 %
3. Vertex Pharmaceuticals Inc
8.44 %
4. Amazon.com Inc
USA
5.85 %
4. Alnylam Pharmaceuticals Inc
8.08 %
5. Meta Platforms A
USA
4.85 %
5. AbbVie Inc
USA
4.91 %
6. Alphabet Inc Class A
USA
4.65 %
6. Gilead Sciences Inc
USA
4.66 %
7. Broadcom Inc
USA
3.68 %
7. Amgen Inc
USA
4.43 %
8. Mastercard Inc
USA
3.51 %
8. BioNTech SE
4.13 %
9. Intuit Inc
3.29 %
9. Karuna Therapeutics Inc
3.75 %
10. ServiceNow Inc
USA
3.25 %
-

The list of fund holdings was last updated on July 25, 2025.